mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.5 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.5 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |